Center for Molecular Analysis of Disease Pathways

What We Do

CMADP's scientific emphasis is on the creation and implementation of enabling technologies that can be employed to identify new therapeutic targets. This includes state of the art methods for gene sequencing, the genetic manipulation of model organisms, custom fluorescent molecular probes for monitoring physiological processes in model organisms, and microfluidic systems for manipulation and monitoring of biochemical pathways.

CMADP capitalizes on existing and evolving expertise in the fields of bioanalytical chemistry, molecular design, genomics and bioengineering at the University of Kansas (KU) and Kansas State University (KSU). The PI, Co-Investigators, research investigators, core directors, mentors, and members of the internal advisory committee represent ten academic departments, six Colleges and Schools, and two Research Centers at KU and KSU. The departments of Biology and Chemistry at KSU are also represented by members of the CMADP's core facility steering committees. The senior faculty members in these departments, schools and centers have a long history of research collaborations and cross-training of graduate students and post-doctoral associates.

Research reported in this website is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103638. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.